Reuters logo
BRIEF-Supernus announces third quarter 2017 financial results
November 6, 2017 / 10:22 PM / a month ago

BRIEF-Supernus announces third quarter 2017 financial results

Nov 6 (Reuters) - Supernus Pharmaceuticals Inc

* Supernus announces third quarter 2017 financial results

* Q3 earnings per share $0.29

* Q3 earnings per share view $0.27 -- Thomson Reuters I/B/E/S

* Sees full year 2017 net product sales guidance range to $290 million to $295 million​

* Sees ‍FY 2017 operating income in range of $85 million to $90 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below